Panayiota Papasavva

5PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsSeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
Modifying quality and equity of care: emerging roles of genetic disease modifiers in β-hemoglobinopathies.

|Dec 22, 2023
Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBB Gene Addition and Mutation-Specific RNA Interference.

Lola Koniali, Christina Flouri, Markela I Kostopoulou

|Apr 23, 2022
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.

Carsten W Lederer, Lola Koniali, Tina Buerki-Thurnherr

|Feb 15, 2022
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation.

Panayiota L Papasavva, Petros Patsali, Constantinos C Loucari

|Apr 05, 2019
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.

Panayiota Papasavva, Marina Kleanthous, Carsten W Lederer

Pageof 1

Frequent Collaborators

5 joint publications

Carsten Werner Lederer

2 joint publications

Petros Patsali

2 joint publications

Marina Kleanthous

1 joint publications

Stefania La Grutta